The Alliance of Community Health Plans (ACHP) submitted a letter to the Centers for Medicare & Medicaid Services (CMS) about the National Coverage Determination (NCD) for beta amyloid pet scans in dementia and neurodegenerative disease patients.
With promising but uncertain treatments of Alzheimer’s actively in development, testing and early usage, now is not the appropriate time to change an NCD that has been in place and working since 2013.
New from ACHP:
- ACHP Statement on CY2026 MA & Part D Rule
- ACHP Amplifies the Voice of Nonprofit Health Plans with Three New Members
- ACHP Joins Hospital-at-Home Sign-On Letter to Congress
- ACHP Response Letter to 2026 Notice of Benefit and Payment Parameters
- It’s Too Early to Claim Victory on Raising the MA Quality Bar
- ACHP Signs Joint Letter on Good Faith Compliance in Mental Health Parity Final Rule
